ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,365 | -1.0% | 46,948 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $95,304 | +2.0% | 46,948 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $93,427 | -15.7% | 46,948 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $110,797 | +14.2% | 46,948 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $97,000 | -17.1% | 46,948 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $117,000 | +134.0% | 46,948 | +113.9% | 0.00% | +200.0% |
| Q1 2022 | $50,000 | – | 21,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aveo Capital Partners, LLC | 95,715 | $661,000 | 0.29% |
| Quantamental Technologies LLC | 5,148 | $38,000 | 0.01% |
| Tekla Capital Management LLC | 36,068 | $264,000 | 0.01% |
| Hudson Bay Capital Management LP | 35,870 | $263,000 | 0.01% |
| Renaissance Technologies | 80,485 | $589,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 17,333 | $128,000 | 0.00% |
| Advisor Group, Inc. | 55 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 40 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 111 | $1,000 | 0.00% |